- Home
- NDLS vs MYO Comparison
NDLS vs MYO Comparison
Compare NDLS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- MYO
- Stock Information
- Founded
- NDLS 1995
- MYO 2004
- Country
- NDLS United States
- MYO United States
- Employees
- NDLS N/A
- MYO N/A
- Industry
- NDLS Restaurants
- MYO Industrial Specialties
- Sector
- NDLS Consumer Discretionary
- MYO Health Care
- Exchange
- NDLS Nasdaq
- MYO Nasdaq
- Market Cap
- NDLS 29.8M
- MYO 33.2M
- IPO Year
- NDLS 2013
- MYO 2017
- Fundamental
- Price
- NDLS $0.70
- MYO $0.89
- Analyst Decision
- NDLS Hold
- MYO Strong Buy
- Analyst Count
- NDLS 1
- MYO 3
- Target Price
- NDLS N/A
- MYO $7.67
- AVG Volume (30 Days)
- NDLS 402.6K
- MYO 801.8K
- Earning Date
- NDLS 11-05-2025
- MYO 11-10-2025
- Dividend Yield
- NDLS N/A
- MYO N/A
- EPS Growth
- NDLS N/A
- MYO N/A
- EPS
- NDLS N/A
- MYO N/A
- Revenue
- NDLS $494,087,000.00
- MYO $41,643,203.00
- Revenue This Year
- NDLS $1.19
- MYO $24.69
- Revenue Next Year
- NDLS N/A
- MYO $20.91
- P/E Ratio
- NDLS N/A
- MYO N/A
- Revenue Growth
- NDLS N/A
- MYO 65.00
- 52 Week Low
- NDLS $0.55
- MYO $0.71
- 52 Week High
- NDLS $1.74
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- NDLS 51.46
- MYO 52.08
- Support Level
- NDLS $0.61
- MYO $0.71
- Resistance Level
- NDLS $0.74
- MYO $0.88
- Average True Range (ATR)
- NDLS 0.05
- MYO 0.07
- MACD
- NDLS 0.00
- MYO 0.02
- Stochastic Oscillator
- NDLS 61.58
- MYO 69.00
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).